Watch the Webinar
Fill out the form below to watch the webinar.
Coronavirus (COVID-19) Fact vs. Fiction
Hear From Harvard Epidemiology Expert
Tune in to cut through the white noise and to learn what is really going on from a global expert in infectious disease, Marc Lipsitch, Professor of Epidemiology with primary appointment at the Department of Epidemiology and a joint appointment at the Department of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health. Marc is an author of more than 250 peer-reviewed publications on antimicrobial resistance, epidemiological methods, and mathematical modeling of infectious disease and one of the most featured experts in international media surrounding the Coronavirus (COVID-19).
Your questions, answered:
How many people will be infected by Coronavirus?
What disruptions may this cause to my business or personal life?
Will COVID-19 really go away as temperatures rise in the summer?
How do I know what's myth and what's fact? Is this just another flu?
How do I handle coronavirus scenarios in my business?
Webinar Speakers
Marc Lipsitch
Marc Lipsitch is a Professor of Epidemiology with primary appointment in the Department of Epidemiology and a joint appointment in the Department of Immunology and Infectious Diseases, where his wet lab is located. Mr. Lipsitch directs the Center for Communicable Disease Dynamics, a center of excellence funded by the MIDAS program of NIH/NIGMS. He is also the Associate Director of the Interdisciplinary Concentration in Infectious Disease Epidemiology.
Jonathan Edelheit
Jonathan Edelheit is Chairman & Co-founder of the Corporate Health & Wellness Association (CHWA), and Global Healthcare Resources (GHR). Global Healthcare Resources reaches over 2 million executives and professionals through the association’s portfolio of companies and its network. As Chairman, Mr. Edelheit spends much of his time collaborating with C-suite executives of health insurance companies, employers/corporations, brokers, hospitals and numerous governments both domestically and internationally on the adoption of innovation and disruption to produce outlier organizations.
